English
Back
Download
Log in to access Online Inquiry
Back to the Top

D. Boral Capital Maintains Can-Fite BioPharma(CANF.US) With Buy Rating, Maintains Target Price $10

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
+0
Translate
Report
11K Views
Comment
Sign in to post a comment